AI, Consumer Trust and the Future of Health Marketing — January 2026 Roundup

January 2026’s health marketing insights — AI in healthcare, consumer trust shifts, and what’s next for digital health brands.

TGA updates guidance on advertising personalised medical devices

The TGA has clarified how personalised medical devices can be advertised in Australia. For health brands working with diagnostics, custom devices, or AI-driven personalisation, this update is a timely reminder of where the line sits between education, promotion, and restricted claims.. Read more →

Australian digital health year in review, AI goes mainstream

AI is no longer a future concept in Australian digital health, it is becoming part of everyday services and patient expectations. This review offers a clear snapshot of how the sector evolved in 2025 and what health brands should factor into their 2026 strategies. Read more →

Google AI Overviews and the risk of misleading health information

More and more people are turning to AI-generated answers to understand symptoms or make health decisions. This investigation highlights how Google’s AI Overviews can sometimes deliver misleading health advice, raising important questions around trust, responsibility, and how health brands should approach visibility and accuracy in an AI-driven search landscape.. Read more →

Generative AI in pharma marketing is moving from tests to reality

2025 was the year many pharma and health brands experimented with generative AI. 2026 is shaping up to be the year where AI becomes operational, governed, and measurable. This piece explores how global pharma marketers are moving beyond pilots, and what this shift means for content production, compliance workflows, and trust in regulated industries. Read more →

New eSafety age-restricted content rules now in effect

New eSafety codes are reshaping how sensitive health content is surfaced in Australia, particularly for younger audiences. These changes have direct implications for SEO, content language, and how health brands approach education topics touching on mental health, eating disorders, or self-harm. Read more →

OpenAI launches ChatGPT Health

Interest in longevity and performance health products is growing fast in Australia, but so is scrutiny around how they’re marketed. This investigation highlights why evidence-based messaging, compliance, and trust signals will become even more critical for health brands in 2026. Read more →

What will the health media landscape look like in 2026?

MM+M explores the major forces shaping how health audiences will consume media in 2026. Topics include the decline of linear TV, the growing influence of AI on content discovery and personalisation, and continuing struggles against misinformation. This piece provides a forward-looking view of what platforms, content formats, and audience behaviours are likely to matter most for health brands next year. Read more →

OpenAI launches OpenAI for Healthcare — a suite of AI tools for regulated health environments

OpenAI has launched OpenAI for Healthcare, a set of AI products designed for clinical, administrative and research workflows in regulated healthcare environments. The suite includes ChatGPT for Healthcare, a secure enterprise-grade workspace, and OpenAI’s API platform configured to support HIPAA-compliant use, identity-based access and audit controls for organisations building AI-powered solutions in clinical and operational settings. Read more →